ESC 365 - Causes and impact on survival of omission of ACE-inhibitors and angiotensin II receptor blockers in heart failure.

HFA Premium Access

Causes and impact on survival of omission of ACE-inhibitors and angiotensin II receptor blockers in heart failure.

Session: Poster Session 4 - Renin-angiotensin-aldosterone antagonists

Topic: Renin-angiotensin-aldosterone antagonists

Speaker: Associate Professor P. Ameri (Genova, IT)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Associate Professor Pietro Ameri

University of Genoa, Genova (Italy)

6 presentations

1 follower

3 more presentations in this session

Improvement in central haemodynamic parameters by association of angiotensin II receptors blockers and canrenone therapy in obese hypertensive patients

Speaker: Doctor C. Paterno Marchioli (Castiglion Fiorentino (AR), IT)

Safety and benefits of the use of an uptitration protocol in patients with heart failure and reduced ejection fraction followed in an heart failure unit

Speaker: Doctor A. Giraldez Valpuesta (Jerez de la Frontera, ES)

Mineralocorticoid receptor antagonists: do we use them enough in very elderly patients with heart failure and severe left ventricular dysfunction?

Speaker: Miss M. Martin Mariscal (Madrid, ES)

Access the full session

Poster Session 4 - Renin-angiotensin-aldosterone antagonists

Speakers: Associate Professor P. Ameri, Doctor C. Paterno Marchioli, Doctor A. Giraldez Valpuesta, Miss M. Martin Mariscal

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources